Meningococcal Vaccines Market to reach US$4.4 bn by 2022,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Meningococcal Vaccines Market to reach US$4.4 bn by 2022, Rising Demand for Halal Vaccines to Propel Market

Albany - New York, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has recently published a report on the global meningococcal vaccines market, according to which the market is estimated to expand at a healthy CAGR of 12.40% during the period between 2014 and 2022.The research report, titled “Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022,” projects this market to rise from an overall value of US$1.5 bn in 2013 to US$4.4 bn by the end of the forecast period.

Research Report with ToC and Free Analysis:  http://www.transparencymarketresearch.com/men...arket.html

Meningococcal infections such as meningococcemia, meningococcal pneumonia, and Meningitis are caused by Neisseria meningitidis and carry a high risk of mortality if left untreated. However, these infections can be prevented by meningococcal vaccines. Various versions of these vaccines are 85% to 100% efficient against different types of meningococcus, resulting in a swift recovery from sepsis and meningitis.

The meningococcal vaccines market has gained a significant impetus in the global arena in recent years, thanks to the advancement of the medical and healthcare industry in emerging economies. The increasing concerns over the growing incidence of meningitis and sepsis have also fueled the demand for these vaccines significantly across the world, states the report.

The research report has evaluated the worldwide meningococcal vaccines market on the basis of the type of meningococcal vaccine and the geographical distribution of this market. Based on the type, the market has been segmented into conjugate vaccines, men b vaccines, combination vaccines, and polysaccharide vaccines. In terms of revenue, the conjugate vaccines segment is expected to dominate the global market for meningococcal vaccines in the coming years. During the forecast period, the segment is likely to rise at a CAGR of 11.10% and reach a value of US$3.1 bn by the end of it.

Download free exclusive Brochure of this report:  http://www.transparencymarketresearch.com/sam...ep_id=1666

On the regional basis, the worldwide meningococcal vaccines market has been segmented into Asia Pacific, Europe, North America, and the Rest of the World. In 2013, North America held the leading position in this market. However, Asia Pacific is likely to emerge as the fastest growing regional market for meningococcal vaccines over the forecast period. The continual rise in the region’s population base and the increasing focus on preventive measures against meningococcal infections are the major factors driving the growth of this regional market, states the research report.

The report also studies the competitive landscape of the global market for meningococcal vaccines by profiling the key companies operating in this market. Serum Institute of India Ltd., Sanofi SA, Pfizer Inc., Nuron Biotech Inc., JN-International Medical Corp., GlaxoSmithKline Plc, Biomed Pvt. Ltd., Novartis International AG, and Baxter International Inc. have been identified as the leading meningococcal vaccine producers in the global arena. Among these, Sanofi, GSK Plc, and Novartis International dominate the worldwide market with a collective share of approximately 90%, notes the market study.

Browse Press Release on Meningococcal Vaccines Market: http://www.transparencymarketresearch.com/pre...market.htm

The global meningococcal vaccines market is segmented as follow:

Meningococcal Vaccines Market, by Type

  • Polysaccharide Vaccines, by Brand
    • Menomune
    • Mencevax
    • NmVac4
    • Others
      • Quadri Meningo
      • Bi Meningo
    • Conjugate Vaccines, by Brand
      • Menactra
      • Menveo
      • NeisVac-C
      • Nimenrix
      • Meningitec
      • Menjugate
      • MenAfriVac
      • NmVac4-DT
    • Combination Vaccines, by Brand
      • MenHibrix
      • Menitorix
    • Men B Vaccines, by Brand
      • Bexsero
      • Trumenba

Meningococcal Vaccines Market, by Geography

  • North America
    • S.
    • Canada
  • Europe
    • K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Africa
    • Rest of RoW

Browse Other Research Reports:

About Us

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us: Rohit Bhisey Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Kayne Anderson-BKM Snaps Up $1.81B in Industrial Real Estate

Updated Category News Views 13

Big Moves in Light Industrial Real Estate That's Making Waves In a market where it's often about go big or go home, Kayne Anderson Real Estate and BKM Capital Partners are swinging for the fences. The duo ponied up a whopping $1.81 billion for a portfolio that ain't your average strip mall corner. We're talking 8.5 million square feet splashed over 51 multitenant light...

Continue Reading
Michelin Stocks Gain Amid Analyst Optimism on Earnings Call

Updated Category News Views 282

Michelin Shares Show Positive Movement Paris-listed shares in Michelin (EPA: MICP) saw an uptick in midday trading, driven by strategic analyst insights shared during a pre-earnings call. This optimism from the investment community holds substantial weight, particularly as it pertains to the tire maker's projected performance. Analysts' Insights from the Earnings Call In...

Continue Reading
Understanding Market Sentiment Around TJX Companies' Stock

Updated Category News Views 134

Market Sentiment Towards TJX Companies TJX Companies, traded under the ticker TJX, has recently seen a noteworthy change in its short percent of float, a key market indicator. The company's short interest has decreased by 4.13%, with about 12.99 million shares sold short, accounting for 1.16% of all available trading shares. Given the current trading volume, traders could...

Continue Reading
CuriosityStream Achieves New Milestones in Streaming Market

Updated Category News Views 67

CuriosityStream Stock Reaches New Heights CuriosityStream Inc. (CURI), a leading player in the factual entertainment space, has recently achieved an impressive milestone by reaching a 52-week high with its stock price now at $2.19. This remarkable performance reflects a surge in investor confidence and highlights how well the market has responded to CuriosityStream's...

Continue Reading
First Industrial Realty Trust Announces Q2 2025 Results Call Details

Updated Category News Views 149

First Industrial Realty Trust to Host Q2 2025 Results Call First Industrial Realty Trust, Inc. (NYSE: FR), a premier owner, operator, and developer within the logistics real estate market, is gearing up for its second quarter 2025 results conference call. The scheduled date for this informative session is on Thursday, July 17, 2025, starting at 10:00 a.m. CDT. Accessing...

Continue Reading